Benitec Biopharma BNTC Stock
Benitec Biopharma Price Chart
Benitec Biopharma BNTC Financial and Trading Overview
| Benitec Biopharma stock price | 9.23 USD |
| Previous Close | 9.58 USD |
| Open | 9.71 USD |
| Bid | 7 USD x 200 |
| Ask | 12.37 USD x 200 |
| Day's Range | 8.92 - 9.88 USD |
| 52 Week Range | 8.92 - 16.76 USD |
| Volume | 135.14K USD |
| Avg. Volume | 142.04K USD |
| Market Cap | 313.25M USD |
| Beta (5Y Monthly) | 0.266 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.98 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 24.33 USD |
BNTC Valuation Measures
| Enterprise Value | 134.04M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.9532908 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.7460625 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -2.621 |
Trading Information
Benitec Biopharma Stock Price History
| Beta (5Y Monthly) | 0.266 |
| 52-Week Change | -30.78% |
| S&P500 52-Week Change | 14.15% |
| 52 Week High | 16.76 USD |
| 52 Week Low | 8.92 USD |
| 50-Day Moving Average | 11.99 USD |
| 200-Day Moving Average | 11.92 USD |
BNTC Share Statistics
| Avg. Volume (3 month) | 142.04K USD |
| Avg. Daily Volume (10-Days) | 209.46K USD |
| Shares Outstanding | 34.88M |
| Float | 18.45M |
| Short Ratio | 16.23 |
| % Held by Insiders | 2.51% |
| % Held by Institutions | 96.01% |
| Shares Short | 2.19M |
| Short % of Float | 10.96% |
| Short % of Shares Outstanding | 6.27% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:17 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2026 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | June 30, 2027 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -22.67% |
| Return on Equity (ttm) | -33.20% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -51134000 USD |
| Net Income Avi to Common (ttm) | -45546000 USD |
| Diluted EPS (ttm) | -0.92 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 179.97M USD |
| Total Cash Per Share (mrq) | 5.16 USD |
| Total Debt (mrq) | 762K USD |
| Total Debt/Equity (mrq) | 0.43 USD |
| Current Ratio (mrq) | 33.998 |
| Book Value Per Share (mrq) | 5.143 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -16518000 USD |
| Levered Free Cash Flow (ttm) | -2748000 USD |
Profile of Benitec Biopharma
| Country | United States |
| State | CA |
| City | Hayward |
| Address | 3940 Trust Way |
| ZIP | 94545 |
| Phone | 510 780 0819 |
| Website | https://benitec.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 24 |
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines in the United States. Its Silence and Replace, a DNA-directedRNA interference platform, that combines RNA interference with gene therapy to create medicines which simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene, which is in phase 1b/2a for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
Q&A For Benitec Biopharma Stock
What is a current BNTC stock price?
Benitec Biopharma BNTC stock price today per share is 9.23 USD.
How to purchase Benitec Biopharma stock?
You can buy BNTC shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Benitec Biopharma?
The stock symbol or ticker of Benitec Biopharma is BNTC.
Which industry does the Benitec Biopharma company belong to?
The Benitec Biopharma industry is Biotechnology.
How many shares does Benitec Biopharma have in circulation?
The max supply of Benitec Biopharma shares is 34.88M.
What is Benitec Biopharma Price to Earnings Ratio (PE Ratio)?
Benitec Biopharma PE Ratio is now.
What was Benitec Biopharma earnings per share over the trailing 12 months (TTM)?
Benitec Biopharma EPS is -0.98 USD over the trailing 12 months.
Which sector does the Benitec Biopharma company belong to?
The Benitec Biopharma sector is Healthcare.
Benitec Biopharma BNTC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27477.31 USD — |
+1.05
|
7.04B USD — | 27223.49 USD — | 27544.06 USD — | — - | 7.04B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
129.28 USD — |
+0.06
|
— — | 128.16 USD — | 129.67 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1320 USD — |
+1.33
|
— — | 1298.21 USD — | 1322.56 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
33942.38 USD — |
+1.05
|
— — | 33628.84 USD — | 34024.84 USD — | — - | — — |
- {{ link.label }} {{link}}
